|
b-thromboglobulin |
bTG |
|
11-dehydrothromboxane B2 |
11-DOH |
|
Activated partial thromboplastin time |
APTT, PTT |
|
Activated protein C |
APC |
|
Activated protein C resistance |
APCR |
|
Acute myocardial infarction |
AMI |
|
Adenosine diphosphate |
ADP |
|
Adenosine triphosphate
Anti-cardiolipin antibody
Anti-phospholipid antibody |
ATP
ACA
APL
|
|
|
|
|
Aspirin |
ASA |
|
Atrial fibrillation |
AFIB |
|
Bernard-Soulier syndrome |
BSS |
|
Cerebrovascular accident |
CVA |
|
Coronary artery bypass graft |
CABG |
|
D-dimer |
D-D |
|
Deep venous thrombosis |
DVT |
|
Dilute Russell viper venom time |
DRVVT |
|
Direct thrombin inhibitor |
DTI |
|
Disseminated intravascular coagulation |
DIC |
|
Ecarin clotting time |
ECT |
|
Endothelial cell |
EC |
|
Factor V Leiden mutation |
FVL |
|
Fibrinogen |
Fg |
|
Fibrin (ogen) degradation products |
FDP |
|
Fibrin (ogen) split products |
FSP |
|
Fibroblast |
FB |
|
Fresh frozen plasma |
FFP |
|
Glanzmann thrombasthenia |
GT |
|
Glycoprotein IIb |
GPIIb |
|
Heparin-induced thrombocytopenia with thrombosis |
HIT, HITT |
|
High molecular weight kininogen (Fitzgerald factor) |
HMWK |
|
Homocysteine |
HCY |
|
Hormone replacement therapy |
HRT |
|
Human platelet antigen |
HPA |
|
Immune (idiopathic) thrombocytopenic purpura |
ITP |
|
International normalized ratio |
INR |
|
International reference preparation |
IRP |
|
International sensitivity index |
ISI |
|
Interleukin |
IL |
|
Intracranial hemorrhage |
ICH |
|
Intramuscular |
IM |
|
Intravascular |
IV |
|
Lupus anticoagulant |
LA, LAC |
|
Low molecular weight heparin |
LMWH |
|
Neonatal alloimmune thrombocytopenic purpura |
NAIT |
|
Normal plasma |
NP |
|
Oral anticoagulant therapy |
OAT |
|
Oral contraceptive |
OCR |
|
Percutaneous coronary intervention |
PCI |
|
Peripheral artery occlusion |
PAO |
|
Platelet |
PLT |
|
Platelet factor 4 |
PF4 |
|
Platelet-free plasma |
PFP |
|
Platelet function analyzer |
PFA |
|
Platelet-poor plasma |
PPP |
|
Plasmin-antiplasmin |
PAP |
|
Plasminogen activator inhibitor-1 |
PAI-1 |
|
Pooled normal plasma |
PNP |
|
Post-transfusion purpura |
PTP |
|
Prekallikrein (Fletcher factor) |
PK |
|
Prostaglandin |
PG |
|
Protein C |
PC |
|
Protein S |
PS |
|
Proteins in vitamin K antagonism |
PIVKA |
|
Prothrombin complex concentrate |
PCC |
|
Prothrombin fragment 1+2 |
PF 1+2 |
|
Prothrombin time (protime) |
PT |
|
Prothrombin time ratio |
PTR |
|
Pulmonary embolism |
PE |
|
Red blood cell |
RBC |
|
Russell viper venom time |
RVVT |
|
Smooth muscle cell |
SMC |
|
Serine protease inhibitor |
SERPIN |
|
Solid-phase red blood cell agglutination assay |
SPRCA |
|
Staphylokinase |
SAK |
|
Streptokinase |
SK |
|
Subcutaneous |
SC, SQ |
|
Thrombin activated fibrinolysis inhibitor |
TAFI |
|
Thrombin-antithrombin |
TAT |
|
Thrombin clotting time |
TCT, TT |
|
Thrombotic thrombocytopenic purpura |
TTP |
|
Thrombomodulin |
TM |
|
Thromboxane A2 |
TXA2 |
|
Thromboxane B2 |
TXB2 |
|
Tissue factor |
TF |
|
Tissue plasminogen activator |
TPA |
|
Transient ischemic attack |
TIA |
|
Tumor necrosis factor |
TNF |
|
Twice a day |
BID |
|
Unfractionated (standard) heparin |
UFH |
|
Unstable angina |
UA |
|
Urokinase |
UK |
|
Venous thromboembolism |
VTE |
|
von Willebrand disease |
vWD |
|
von Willebrand factor |
vWF |
|
White blood cell |
WBC |
